Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Trop-2 as a Therapeutic Target in Breast Cancer.
Sakach E, Sacks R, Kalinsky K. Sakach E, et al. Cancers (Basel). 2022 Nov 30;14(23):5936. doi: 10.3390/cancers14235936. Cancers (Basel). 2022. PMID: 36497418 Free PMC article. Review.
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.
Kalinsky K, Accordino MK, Chiuzan C, Mundi PS, Sakach E, Sathe C, Ahn H, Trivedi MS, Novik Y, Tiersten A, Raptis G, Baer LN, Oh SY, Zelnak AB, Wisinski KB, Andreopoulou E, Gradishar WJ, Stringer-Reasor E, Reid SA, O'Dea A, O'Regan R, Crew KD, Hershman DL. Kalinsky K, et al. Among authors: sakach e. J Clin Oncol. 2023 Aug 20;41(24):4004-4013. doi: 10.1200/JCO.22.02392. Epub 2023 May 19. J Clin Oncol. 2023. PMID: 37207300 Clinical Trial.
CDK4/6 Inhibition in the Metastatic Setting: Where Are We Headed?
Sakach E, Keskinkilic M, Wood S, Canning M, Kalinsky K. Sakach E, et al. Curr Treat Options Oncol. 2023 Sep;24(9):1103-1119. doi: 10.1007/s11864-023-01109-9. Epub 2023 Jun 14. Curr Treat Options Oncol. 2023. PMID: 37314645 Review.
Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days on/7 Days off Schedules of Capecitabine in Patients with Metastatic Colorectal Cancer: A Retrospective Review.
Bryson E, Sakach E, Patel U, Watson M, Hall K, Draper A, Davis C, Goyal S, Alese O, Akce M, Shaib W, El-Rayes B, Szabo S, Wu C. Bryson E, et al. Among authors: sakach e. Clin Colorectal Cancer. 2021 Jun;20(2):153-160. doi: 10.1016/j.clcc.2020.12.002. Epub 2021 Mar 23. Clin Colorectal Cancer. 2021. PMID: 33741260
Two cancers in one: breast carcinoma with underlying melanoma.
Douville NA, Sakach EA, Wiewiorowski EA, Herlihy W, Pippen JE Jr. Douville NA, et al. Among authors: sakach ea. Proc (Bayl Univ Med Cent). 2017 Jul;30(3):316-318. doi: 10.1080/08998280.2017.11929630. Proc (Bayl Univ Med Cent). 2017. PMID: 28670070 Free PMC article.